Oncology / cGVHD

Chronic Graft-versus-Host Disease: Biomarkers, Mediators, and Druggable Targets

clinical topic updates by David Miklos, MD, PhD

An improved understanding of chronic graft-versus-host disease (cGVHD) and its pathogenesis has led to the development of novel treatments. Future ......READ MORE

cGVHD

Evolving Transplant Technology and Chronic Graft-versus-Host Disease

patient care perspectives by Edmund K. Waller, MD, PhD, FACP

cGVHD

Advancements in the Management of Chronic Graft-versus-Host Disease

expert roundtables by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and Edmund K. Waller, MD, PhD, FACP

cGVHD

Incorporating Novel and Conventional Agents in Chronic Graft-versus-Host Disease

expert roundtables by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and Edmund K. Waller, MD, PhD, FACP

LATEST IN Oncology

Browse More Articles